Skyscape Web Viewer : DrDrugs®: Canadian Drug Guide for Physicians : Pharmacologic Index

View All
leptin analogues
leukotriene antagonists montelukast zafirlukast
lincosamides
lipase inhibitors
lipid calorie sources
lipoglycopeptides dalbavancin oritavancin telavancin
long-acting beta2-adrenergic agonists (LABAs) budesonide/formoterol/glycopyrrolate glycopyrrolate/formoterol umeclidinium/vilanterol
loop diuretics bumetanide diuretics (loop) ethacrynic acid furosemide torsemide
low molecular weight heparins dalteparin danaparoid enoxaparin
lubricant laxatives
luteinizing hormone-releasing hormone (LHRH) analogues
macrolides azithromycin clarithromycin erythromycin fidaxomicin
mast cell stabilizers
Mechanistic target of rapamycin kinase inhibitors
meglitinides nateglinide repaglinide
melanocortin receptor agonists afamelanotide bremelanotide setmelanotide
melatonin receptor agonists ramelteon tasimelteon
metabolic inhibitors
microsomal transfer protein inhibitors
mineralocorticoid receptor antagonists non steroidal
minerals electrolytes fluoride supplements magnesium sulfate (parenteral)
monamine oxidase inhibitors isocarboxazid moclobemide phenelzine tranylcypromine
monoamine oxidase type b inhibitors rasagiline safinamide selegiline
monobactams aztreonam aztreonam/avibactam
monoclonal antibodies adalimumab alemtuzumab alirocumab amivantamab anifrolumab atezolizumab avelumab axatilimab basiliximab belimumab benralizumab bevacizumab bimekizumab blinatumomab burosumab caplacizumab cemiplimab certolizumab cetuximab concizumab crizanlizumab crovalimab daratumumab daratumumab/hyaluronidase datopotamab deruxtecan denosumab dinutuximab donanemab dostarlimab durvalumab elotuzumab elranatamab emapalumab emicizumab eptinezumab erenumab evinacumab evolocumab fam-trastuzumab deruxtecan faricimab fremanezumab galcanezumab gemtuzumab ozogamicin golimumab guselkumab ibritumomab idarucizumab inebilizumab infliximab ipilimumab isatuximab lanadelumab lebrikizumab lecanemab loncastuximab tesirine margetuximab mepolizumab mogamulizumab natalizumab naxitamab necitumumab nirsevimab nivolumab obinutuzumab ocrelizumab ocrelizumab/hyaluronidase ofatumumab omalizumab pembrolizumab pertuzumab pertuzumab/trastuzumab/hyaluronidase polatuzumab vedotin ranibizumab ravulizumab reslizumab risankizumab rituximab rituximab/hyaluronidase rozanolixizumab satralizumab secukinumab tafasitamab talquetamab teplizumab teprotumumab tezepelumab tildrakizumab trastuzumab trastuzumab/hyaluronidase tremelimumab ublituximab ustekinumab vedolizumab vilobelimab
monoclonal anti-toxins obiltoxaximab raxibacumab
muscarinic agonists
Neonatal Fc receptor blockers efgartigimod alfa efgartigimod alfa/hyaluronidase rozanolixizumab
neprilysin inhibitors
neuraminidase inhibitors oseltamivir peramivir zanamivir